Share on

Global Artificial Insemination Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Type, Source Type, End-User, & Region – Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 12452
Pages: 190
Formats: report pdf report excel report power bi report ppt

Global Artificial Insemination Market Size (2022 TO 2027)

The global artificial insemination market size was worth USD 1.92 billion in 2021. This value is further estimated to be growing at a CAGR of 9.02% from 2022 to 2027 and reach USD 3.22 billion by 2027 from USD 2.09 billion in 2022.

Artificial insemination is a form of assisted reproduction in which live sperm are inserted into a woman's cervix, fallopian tubes, or uterus. Artificial insemination homologous (AIH) or artificial insemination donor semen (AID) procedures are used, both quick and painless. Self-insemination kits are now available on the market and can be utilized in the comfort of one's own home. It is human reproductive treatment and an animal breeding procedure for dairy cattle, pigs, and other animals. There are several procedures for implanting sperm into a woman's womb to increase fertility in women who want to have their kids but are not in a relationship. It is a treatment procedure utilized for many infertile women around the world. Artificial insemination plays a critical part in the generation of cows or bulls in animals since it aids in the fulfillment of human dairy needs. Artificial insemination of bulls or other male animals into the wombs of female animals can let a single bull produce 10,000 or more calves each year without using the natural approach.

Impact of COVID-19 on the global artificial insemination market:

In various countries, the COVID-19 pandemic has had a significant negative impact on multiple sectors. It has disrupted the value chains of cattle and poultry, resulting in a decrease in the procurement and sale of animal-sourced food. In June 2020, the Animal Husbandry Department of India established a telephonic help program for poultry farmers and owners to protect farmers and staff against COVID-19. Similarly, the unexpected emergence of COVID-19 worldwide has had a negative impact on the artificial insemination industry. Due to the lack of child and animal birth, artificial insemination was used in humans and animals. This has been severely influenced due to the concern, and various rules have been made all over the world to avoid the contact of corona-virus infection during the birth of a child.


One of the major factors driving the global artificial insemination market is the rise in infertility rates, accompanied by an increase in public awareness of alternative reproductive treatments.

Governments in several countries have recognized same-sex marriage and are extending insurance coverage to civil unions for artificial insemination operations, fueling market growth. Aside from that, the growing global population and demand for animal-based protein are driving the demand for artificial insemination in domestic livestock animals. In addition, veterinary services are improving, and spending on animal healthcare is increasing, helping the market grow further.

The development of new intracytoplasmic sperm injection (ICSI) for child production, which is implanted in the ovum of females, has created a significant opportunity for this sector. Furthermore, rising AI breeding programs combined with global government initiatives for animal products are expected to provide profitable growth opportunities in the worldwide market. As a result, the need for superior animal breeds is rising globally, driving up the demand for artificial insemination operations in animals. Furthermore, worldwide population expansion, coupled with associated benefits such as lower housing costs, increased bull efficiency, safety for farmers and animals, genetic selection, and bull handling, is expected to fuel market growth in the near future. The artificial insemination market is further expected to develop throughout the forecast period, owing to reasons such as the rising global rate of infertility, changing lifestyles, and modern women's growing choice for Planned Parenthood due to their uninterrupted full-time professional careers.


Lack of professional animal breeding healthcare, a significant danger of diseases, and the risk of birth deformities in children for human reproduction is predicted to stifle market expansion in the near future. According to dairy cow owners, conception failure, mastitis, calving challenges (death or dystocia), and mixed disorders were the most common animal health concerns connected with artificial insemination.




Market Size Available

2021 to 2027

Base Year


Forecast Period

2022 to 2027

Segments Covered

By Type, Source Type, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa


This research report on the global artificial insemination market has been segmented and sub-segmented based on type, source type, end-user, and region.

Artificial Insemination Market – By Type:

  • Intrauterine
  • Intracervical
  • Intravaginal
  • Intratubal

Intrauterine insemination held the dominating share of the global artificial insemination market in 2021. It is predicted to be the fastest-growing segment over the forecast period. This insemination method is the most popular for treating infertility since it results in the highest pregnancy rate. It's also a non-invasive procedure. The second-largest portion is expected to be intravaginal (IVI). Surrogacy and donor insemination can benefit from IVI, which can be done at a fertility clinic or at home.

Artificial Insemination Market – By Source:

  • AIH-Husband
  • AID-Donor

The Artificial Insemination by Husband (AIH) market was the most popular. It is also predicted to have the most significant CAGR over the forecast period. Donor insemination (AID) is the last resort for couples with non-viable sperm. Single women and same-sex couples can also get AID. Because sperm banks must disclose personal medical and lengthy family histories of donors, donor insemination has proven to be safe.

Artificial Insemination Market – By End-User:

  • Hospitals and Clinics
  • Fertility Centers
  • Others

Based on the end-user, the fertility centers had the largest share in the global artificial insemination market and are expected to grow quickly over the forecast period. Due to rising fertility rates worldwide, the number of medical institutes offering infertility treatment has expanded in recent years. As a result, fertility clinics can undertake all forms of artificial insemination techniques.

Artificial Insemination Market – By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Because of advanced technology, government backing for fertility insurance, and increased awareness of the treatment option for infertility, the North American artificial insemination market accounted for the major share of the global market in 2021. According to the group, around 10% of American women of childbearing age have had therapy for infertility. Infertility treatment procedures such as artificial insemination and hormone therapy to boost egg production, known as assisted reproductive technology, are driving regional market expansion.

Due to the expanding population, Asia Pacific artificial insemination market is expected to be the fastest-growing region throughout the forecast period in the global market, necessitating the use of animals for dairy products and satisfying daily food demands. Such elements are boosting regional expansion through increasing regional market demand for artificial insemination in animal production. In addition, the rate of infertility in large population areas such as India and China has been a driving force behind this market's expansion. The elements driving the development are rising milk consumption and an increase in the number of semen stations in the country. In addition, the rise of the market is likely to be aided by increasing disposable income in developing countries.

The Latin American artificial insemination market is forecasted to showcase a CAGR of 9.94% from 2022 to 2027.


Rocket Medical, INVO Bioscience, Vitrolife, Pride Angel, Genea Limited, MedGyn Products, Inc., Rinovum Women's Health, Conceivex Inc., Tenderneeds Fertility, Hi-Tech Solutions, Fujifilm Irvine Scientific, and Kitazato Corporation are a few of the leading companies operating in the global artificial insemination market and profiled in this report.


  • In August 2020, Cogent partnered with AB Europe, a sheep breeding company, to develop a sexed semen service for sheep producers in the United Kingdom.
  • The Indian government approved a USD 2.13 billion investment for initiatives to create animal husbandry infrastructures in May 2020.
  • Madras Veterinary College's Department of Veterinary, Gynecology, and Obstetrics initiated artificial insemination in cattle using sexed semen in August 2019.
  • JXTGE announced the sale of Irvine Scientific to FUJIFILM in March 2018 to maximize synergies and continue to grow in the biomedical market.

Please wait. . . . Your request is being processed


How big is the artificial insemination market?

The global artificial insemination market size is estimated to be worth USD 3.22 billion by 2027 and was valued at USD 1.92 billion in 2021. 

Which segment by type is expected to lead the artificial insemination market in the coming years?

The intrauterine segment is predicted to showcase dominance in the global artificial insemination market from 2022 to 2027.

Which region led the artificial insemination market in 2021?

The North American region accounted for the majority of the share in the global artificial insemination market in 2021.

Which are the companies playing a key role in the artificial insemination market?

Rocket Medical, INVO Bioscience, Vitrolife, Pride Angel, Genea Limited, MedGyn Products, Inc., Rinovum Women's Health, Conceivex Inc., Tenderneeds Fertility, Hi-Tech Solutions, Fujifilm Irvine Scientific, and Kitazato Corporation are some of the major companies operating in the artificial insemination market.

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample